Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline and Low Oxygen Therapy for Walking Function in Spinal Cord Injury
NCT05217498Phase 2Not yet recruiting
- Start
- Sep 2027
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Istradefylline in spinal cord injury (SCI). Planned start Sep 2027; status: not yet recruiting.
02
Drugs
Istradefylline
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05217498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05217498.